← Back to headlines
Agilent Receives Expanded Approval for Diagnostic Test for Keytruda Patients
Agilent has secured expanded approval for its diagnostic test, which is designed to identify potential patients for Keytruda, a prominent cancer immunotherapy drug.
3 Jun, 14:47 — 3 Jun, 14:47
Sources
Showing 1 of 1 sources
